The LSHTM team has been analysing B.1.1.7 for signs of increased or decreased severity since late December. We first identified a signal of higher mortality in mid-January. This led to an announcement by the PM and @uksciencechief on 22 January. https://www.bbc.co.uk/news/health-55768627 … 2/16
-
-
Show this thread
-
In that early report, we estimated that B.1.1.7 was associated with a ~35% increase in mortality, based on around 2600 deaths, of which 384 had the SGTF marker for B.1.1.7. Our updated analysis is based on 4900 deaths, around 3100 of which had SGTF. 3/16pic.twitter.com/dQFd0s2Efx
Show this thread -
Using a statistical technique called a Cox proportional hazards model, we found that people infected with B.1.1.7 had a 55% (95% CI 39–72%) higher rate of mortality within 28 days of receiving a positive test. 4/16pic.twitter.com/b5ChqT8IbE
Show this thread -
The analysis controls for age, sex, deprivation, ethnicity & care home/residential/other residence type. We only compare death rates among people living in the same local authority, who were tested on the same day, to control for changes in test rates and hospital pressure. 5/16pic.twitter.com/YNgetw9Vls
Show this thread -
We did not find any statistically significant differences in the increased mortality rate associated with B.1.1.7 by age, sex, IMD, ethnicity, or residence type. 6/16pic.twitter.com/EqK4oTBaUz
Show this thread -
-
While we use a statistical model to account for all the confounding factors, you do not need a model to see that B.1.1.7 is associated with higher mortality in this study sample. The raw data show the pattern clearly. The stats are there to get a clearer estimate. 8/16pic.twitter.com/noGn8q5kBR
Show this thread -
I think the most convincing way of looking at the raw data is by comparing the observed number of deaths per follow-up day, stratified here by a number of characteristics. Diamonds higher than circles = increased mortality among subjects with SGTF (the marker for B.1.1.7). 9/16pic.twitter.com/ZVP5FnFgpz
Show this thread -
Our study sample is people tested in the community. If those infected with B.1.1.7 were less likely to get a test, we might only detect severe cases & hence overestimate mortality. But we found no major differences in test seeking (if anything, slight increase for B.1.1.7). 10/16pic.twitter.com/V2Y05Kaq4A
Show this thread -
Other groups working contemporaneously and since have found similar results: Challen et al https://www.bmj.com/content/372/bmj.n579 … Grint et al https://www.medrxiv.org/content/10.1101/2021.03.04.21252528v1.full.pdf … Patone et al https://www.medrxiv.org/content/10.1101/2021.03.11.21253364v1.full.pdf … Bager et al (Denmark) https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3792894 … And others https://www.gov.uk/government/publications/nervtag-update-note-on-b117-severity-11-february-2021 … 11/16
Show this thread -
Overall, the emerging picture is pretty consistent. 12/16pic.twitter.com/WD4OwFpiwm
Show this thread -
What does this mean? First, it helps to explain why the UK has seen so many COVID-19 deaths in the last three months, together with the increased infectiousness of B.1.1.7, as we described here: https://science.sciencemag.org/content/early/2021/03/03/science.abg3055 … 13/16
Show this thread -
Second, it adds more evidence that other countries may have a difficult time in the months ahead. Vaccines are effective against B.1.1.7 and will help a lot. https://science.sciencemag.org/content/371/6534/1152 … https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3779160 … 14/16
Show this thread -
Thanks to: coauthors
@Jarvis_Stats John Edmunds@NP_Jewell@karlado@RuthHKeogh;@cmmid_lshtm &@LSHTM; peer reviewers;@rjchallen,@leondanon, SPI-M & NERVTAG for discussions. Big thanks to @PHE_uk for allowing us to release anonymised data: https://github.com/nicholasdavies/cfrvoc … 15/16Show this thread -
And for funding support, thanks to
@NIHRresearch@UKRI_News@The_MRC@GCRF@ESRC@EU_Commission@NIH@NIAIDNews@royalsociety@wellcometrust. 16/16Show this thread
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.